Results 61 to 70 of about 2,205,036 (277)
International Journal of Nephrology, 2015 Background/Aims. Acute kidney injury is a common problem for patients with cirrhosis and is associated with poor survival. We aimed to examine the association between type of acute kidney injury and 90-day mortality. Methods.
Andrew S. Allegretti +9 more
doaj +1 more source
Terlipressin effect on hepatorenal syndrome: Updated meta‐analysis of randomized controlled trials
JGH Open, 2021 Hepatorenal syndrome (HRS) is a fatal complication of liver cirrhosis with a limited pharmacological option. Terlipressin is a vasoconstrictor that is approved in many countries but not yet in the United States.
Mohamed M. G. Mohamed +5 more
semanticscholar +1 more source
Recent advances in the understanding and management of hepatorenal syndrome
Faculty Reviews, 2021 Renal dysfunction occurs frequently in hospitalized patients with advanced chronic liver disease (ACLD)/cirrhosis and has profound prognostic implications.
B. Simbrunner +3 more
semanticscholar +1 more source
Nephrogenic systemic fibrosis risk and liver disease. [PDF]
, 2014 Objective. Evaluate the incidence of nephrogenic systemic fibrosis (NSF) in patients with liver disease in the peritransplant period. Materials and Methods. This IRB approved study retrospectively reviewed patients requiring transplantation for cirrhosis,
Chow, Daniel S +6 more
core +3 more sources
Journal of Clinical Medicine, 2021 Hepatorenal syndrome (HRS) is a type of acute kidney injury (AKI), occurring in patients with decompensated liver cirrhosis and is associated with high mortality.
Roula Sasso, A. Abou Yassine, L. Deeb
semanticscholar +1 more source
Beta-blokers in patients with cirrhosis and infection: don't blame too soon. [PDF]
, 2015 We found that PPI-users had a higher rate and BBs-users a lower rate of infections. The lower infection rate and better prognosis of BB-users can not be attributed, as suggested by Schiavon et al., to a higher proportion of variceal bleeding in this ...
LUCIDI, CRISTINA +3 more
core +1 more source
Hepatorenal syndrome: pathophysiology and evidence-based management update
Romanian journal of internal medicine = Revue roumaine de medecine interne, 2021 Hepatorenal syndrome (HRS) is a functional renal failure that develops in patients with advanced hepatic cirrhosis with ascites and in those with fulminant hepatic failure.
Irtiza Hasan +4 more
semanticscholar +1 more source
MELD score predicts outcomes in patients with advanced heart failure: A longitudinal evaluation
ESC Heart Failure, Volume 12, Issue 2, Page 839-847, April 2025.Abstract Aims Advanced heart failure (AHF) is characterized by recurrent episodes of haemodynamic instability and frequent hospitalizations, leading to a progressive decline in quality of life and high mortality rates. The objectives of this study were to evaluate the effect of the model for end‐stage liver disease (MELD) score and its variations in ...
Francesco Curcio +10 more
wiley +1 more source
It is reasonable to treat patients with type 1 hepatorenal syndrome with midodrine and octreotide [PDF]
, 2016 A critical appraisal and clinical application of Esrailian E, Pantangco ER, Kyulo NL, Hu KQ, Runyon BA. Octreotide/midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome. Dig Dis Sci. 2007;
Kane, William
core +2 more sources
Hepatorenal syndrome: a Nationwide Trend Analysis from 2008 to 2018
Annals medicus, 2021 Objective This study was designed to assess the epidemiological trends and outcomes associated with Hepatorenal Syndrome (HRS). Methods This retrospective interrupted trend study used the Nationwide Inpatient Sample (NIS) database for the years 2008 ...
Jagmeet Singh +5 more
semanticscholar +1 more source